Technavio Publishes New Industry Analysis on the Osteoporosis Drugs Market in BRIC Nations from 2015-2019
October 07 2015 - 11:45AM
Business Wire
Technavio has published a new report on the osteoporosis
drugs market in BRIC nations, which is expected to grow at a
CAGR of over 17% from 2015-2019.
About the Report
According to the new report by Technavio, an overall assessment
of the advantages and disadvantages of current osteoporosis
treatment options presents the existence of unmet medical needs for
the available drugs.
“Unmet medical need in terms of safety, efficacy, and compliance
compels researchers to develop drugs that increase bone density,
replace lost bone mass, and rebuild bone strength. For instance,
Pfizer will likely lead the market during the forecast period
through the sales of bazedoxifene, a third generation selective
estrogen receptor modulator,” says Faisal Ghaus, Vice President of
Technavio.
The latest report by Technavio also emphasizes the shift toward
anabolic treatment, which are currently in the late and mid-stages
of development.
“The treatment paradigm of osteoporosis has been stationary for
the past few decades in the BRIC countries. Therefore, the launch
of new efficacious and safe anabolic treatments will be the major
modification in the management of osteoporosis,” adds Ghaus.
Market Scope and Calculation of Market Size
The new Technavio report covers the present scenario and growth
prospects of the osteoporosis drugs market in BRIC nations from
2015-2019. To calculate the market size, we consider revenue
generated from the sales of various branded and generic
pharmaceutical products for treating osteoporosis.
Key Information Covered in the Report:
- Key Vendors:
- Amgen
- Eli Lilly
- Merck
- Novartis
- Market Growth Drivers:
- Rise in aging population
- For a full detailed list, view our
report.
- Market Challenges:
- Expiry of patents
- For a full detailed list, view our
report.
- Market Trends:
- Shift toward anabolic treatment
- For a full detailed list, view our
report.
Technavio currently has more than 3000 market research
reports on a huge range of topics, including 100+ reports on the
osteoporosis drugs market:
- Global Osteoporosis Drugs Market
2015-2019
- Osteoporosis Drugs Market in the APAC
Region 2015-2019
If you are interested in more information, please contact our
media team at media@technavio.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151007005045/en/
Technavio ResearchJesse MaidaUS: +1-630-333-9501UK:
+44-208-123-1770Media & Marketing
Executivewww.technavio.commedia@technavio.com